Moriuchi, Yukiyoshi
Sasebo City General Hospital · Kumamoto University Hospital · Toranomon Hospital · The University of Tokyo
4 papers on CoChat
Most cited papers
- Verified
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
Ishida, T., Jo, T., Takemoto, S., Suzushima, H., Uozumi, K., Yamamoto, K., Uike, N., Saburi, Y., Nosaka, K., Utsunomiya, A., et al. (2015) · British Journal of Haematology
T-cell and Retrovirus StudiesLymphoma Diagnosis and Treatment
Cited by 267
- Verified
Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality
Fuji, S., Inoue, Y., Utsunomiya, A., Moriuchi, Y., Uchimaru, K., Choi, I., Otsuka, E., Henzan, H., Kato, K., Tomoyose, T., et al. (2016) · Journal of Clinical Oncology
Hematopoietic Stem Cell TransplantationT-cell and Retrovirus Studies
Cited by 197
- Verified
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002
Ishida, T., Fujiwara, H., Nosaka, K., Taira, N., Abe, Y., Imaizumi, Y., Moriuchi, Y., Jo, T., Ishizawa, K., Tobinai, K., et al. (2016) · Journal of Clinical Oncology
T-cell and Retrovirus StudiesViral-associated cancers and disorders
Cited by 152
- Verified
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study Group
Itonaga, H., Tsushima, H., Imanishi, D., Hata, T., Doi, Y., Mori, S., Sasaki, D., Hasegawa, H., Matsuo, E., Nakashima, J., et al. (2014) · Leukemia Research
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free